ALKS

Alkermes Stock Analysis

AI Rating

Low
  • Quality8/10
  • Growth 0/10
  • Value 1/10
Alkermes sales and earnings growth
ALKS Growth
Low
  • Revenue Y/Y 0.71%
  • EPS Y/Y -56.74%
  • FCF Y/Y -61.65%
Alkermes gross and profit margin trends
ALKS Profitability
Good
  • Gross margin 86.60%
  • EPS margin 9.80%
  • ROIC 5Y 23.55%
Alkermes net debt vs free cash flow
ALKS Risk
Great
  • Debt / Equity 0.9
  • Debt / FCF 5.5
  • Interest coverage 7.2

Alkermes stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks